1.Effect of Preexisting Musculoskeletal Diseases on the 1-Year Incidence of Fall-related Injuries.
Won Kyung LEE ; Kyoung Ae KONG ; Hyesook PARK
Journal of Preventive Medicine and Public Health 2012;45(5):283-290
OBJECTIVES: People who have chronic diseases, as well as gait imbalance or psychiatric drug use, may be susceptible to injuries from falls and slips. The purpose of this study was to evaluate the effect of musculoskeletal diseases on incidental fall-related injuries among adults in Korea. METHODS: We analyzed data from the 4th Korea National Health and Nutrition Examination Survey (2007-2009), which are national data obtained by a rolling survey sampling method. The 1-year incidence of fall-related injuries was defined by health service utilization within the last year due to injury occurring after a slip and fall, and musculoskeletal diseases included osteoarthritis, rheumatoid arthritis, osteoporosis, and back pain. To evaluate the effects of preexisting musculoskeletal diseases, adults diagnosed before the last year were considered the exposed group, and adults who had never been diagnosed were the unexposed group. RESULTS: The weighted lifetime prevalence of musculoskeletal disease was 32 540 per 100 000 persons. Musculoskeletal diseases were associated with a higher risk of fall-related injury after adjustment for sex, age, residence, household income, education, occupation, visual disturbance, paralysis due to stroke, and medication for depression (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.03 to 1.93). As the number of comorbid musculoskeletal diseases increased, the risk of fall-induced injuries increased (p-value for trend <0.001). In particular, patients who had any musculoskeletal condition were at much higher risk of recurrent fall-related injuries (OR, 6.20; 95% CI, 1.06 to 36.08). CONCLUSIONS: One must take into account the risk of fall-related injuries and provide prevention strategies among adults who have musculoskeletal diseases.
Accidental Falls/*statistics & numerical data
;
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Arthritis, Rheumatoid/complications/epidemiology
;
Back Pain/complications/epidemiology
;
Female
;
Health Surveys
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Musculoskeletal Diseases/*complications
;
Osteoarthritis/complications/epidemiology
;
Osteoporosis/complications/epidemiology
;
Republic of Korea/epidemiology
;
Risk Factors
;
Sex Factors
;
Socioeconomic Factors
;
Young Adult
2.Primary Atrophic Rhinitis with Bilateral Turbinates Agenesis.
Journal of Rhinology 2013;20(2):139-141
In this paper, we report a case of bilateral inferior and middle turbinate agenesis, a rare anomaly. A 27-year-old woman presented with nasal obstruction, crust formation, anosmia, and foul odors. Anterior rhinoscopic examination revealed the absence of the middle and inferior turbinates on both sides. The patient had no history of nasal or sinus surgery. She denied over having expelled anything of significance from her nasal cavity. She had no history of infectious disease-including tuberculosis and syphilis, granuolomatous diseases, sarcoids, Wegener's disease, and radiation therapy. There have been few reports on bilateral turbinate agenesis.
Adult
;
Female
;
Humans
;
Nasal Cavity
;
Nasal Obstruction
;
Odors
;
Olfaction Disorders
;
Rhinitis
;
Rhinitis, Atrophic*
;
Syphilis
;
Tuberculosis
;
Turbinates*
3.Primary Atrophic Rhinitis with Bilateral Turbinates Agenesis.
Journal of Rhinology 2013;20(2):139-141
In this paper, we report a case of bilateral inferior and middle turbinate agenesis, a rare anomaly. A 27-year-old woman presented with nasal obstruction, crust formation, anosmia, and foul odors. Anterior rhinoscopic examination revealed the absence of the middle and inferior turbinates on both sides. The patient had no history of nasal or sinus surgery. She denied over having expelled anything of significance from her nasal cavity. She had no history of infectious disease-including tuberculosis and syphilis, granuolomatous diseases, sarcoids, Wegener's disease, and radiation therapy. There have been few reports on bilateral turbinate agenesis.
Adult
;
Female
;
Humans
;
Nasal Cavity
;
Nasal Obstruction
;
Odors
;
Olfaction Disorders
;
Rhinitis
;
Rhinitis, Atrophic*
;
Syphilis
;
Tuberculosis
;
Turbinates*
4.The Differences Between Cyclosporine and Tacrolimus in the Generation of ROS and Extracellular Matrix Accumulation in Primary Cultured Human Mesangial Cells.
Soong Ku LEE ; Su Jeen LEE ; Hyun Jun KIM ; Gu KONG ; Kyoung Won KAHNG ; Chong Myung KANG
Korean Journal of Nephrology 2001;20(2):187-197
OBJECTIVE: Cyclosporine(CsA) and tacrolimus, albeit different in structure, exert immunosuppressive effect by similar mechanism. Although most of clinical manifestations, including nephrotoxicity, are similar in the patients using these drugs, there are some differences including gum hyperplasia, neurotoxicity, and hepatic fibrosis between two drugs. There are several reports about association between reactive oxygen species(ROS) and CsA. In contrast, tacrolimus is known to decrease ROS in central nervous system. Thus, we investigated the possibility of different effects of tacrolimus and CsA on the generation of ROS, on the synthesis and degradation of collagen. METHODS: Experiments were done in primary cultured mesangial cells between 4th and 8th passages. CsA was added to the culture dishes in different concentration(making final CsA concentration of 0, 2, 4, 8 microgram/milliliter) and N-acetylcysteine(NAC) was also added in another mesangial cell culture at 4 microgram/milliliter of CsA concentration; tacrolimus was added in similar pattern(making final tacrolimus concentration of 0, 0.1, 0.2, 0.4 microgram/milliliter, NAC in 0.2 microgram/milliliter of tacrolimus concentration). RESULTS: No significant decrease in viability was noted in both cell groups, but growth retardation was weak in tacrolimus treated cells comparing with CsA treated cells. By flow cytometry, we could find the generation of ROS in CsA treated cells, but not in tacrolimus treated cells. In RT-PCR, there is no significant difference in m-RNA expression for a number of molecules including collagen III, MMP-2, TIMP-2, MT1-MMP in either CsA treated cells or tacrolimus cells. But in zymogram, MMP-2 activities were decreased at higher CsA concentration, then increased with addition of NAC. In tacrolimus cells, MMP2 activity was not changed at 0.1 and 0.2 microgram/milliliter; but, at the concentration of 0.4 microgram/milliliter, changed and not reversed by NAC. MMP-9 activity was similar in both cells. CONCLUSION: We could find ROS generation in CsA treated human mesangial cells, but not in tacrolimus treated cells. We think this difference resulted in the decrease of post-transcriptional MMP-2 activity in CsA treated cells and we also think tacrolimus cells in our experiments were not influenced by ROS. From these results, tacrolimus and CsA are different in the generation of ROS that have some effects in the matrix accumulation in mesangial cells. These result does not mean that tacrolimus is superior to CsA in nephrotoxicity, because nephrotoxicity is similar between two drugs. In conclusion, the mechanisms of nephrotoxicity are different between CsA and tacrolimus.
Central Nervous System
;
Collagen
;
Cyclosporine*
;
Extracellular Matrix*
;
Fibrosis
;
Flow Cytometry
;
Gingiva
;
Humans*
;
Hyperplasia
;
Matrix Metalloproteinase 14
;
Mesangial Cells*
;
Oxygen
;
Tacrolimus*
;
Tissue Inhibitor of Metalloproteinase-2
5.Therapeutic Plasma Exchanges in Patients with Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome.
Sun Young KONG ; Eun Hae CHO ; Sean Mi SONG ; Hae Kyoung CHOUNG ; Dae Won KIM
Korean Journal of Clinical Pathology 2001;21(5):390-395
BACKGROUND: Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) is a disease entity defined by the presence of thrombocytopenia and microangiopathic hemolytic anemia with or without fever, neurologic and renal symptoms. Therapeutic plasma exchange (TPE) has proven to be an effective treatment for TTP/HUS and has decreased mortality. We evaluated the effectiveness of TPE for TTP/HUS at the Department of Clinical Pathology, Samsung Medical Center during the last 6 years. METHODS: We assessed retrospectively the chief complaints, the clinical course, the treatment and the outcome in 17 TTP/HUS patients treated with TPE from December 1994 to May 2001. Minimal diagnostic criteria for TTP/HUS were unexplained thrombocytopenia and microangiopathic hemolytic anemia, with or without fever, neurologic, and renal symptoms. The range of ages of the patients was 15 to 63 years and the female to male ratio was 2:1. RESULTS: The most frequent clinical presentation was a renal problem (71%), followed by fever (53%) and neurologic symptoms (24%). The causes of TTP/HUS followed in the order of frequency: idiopathic (41%), suspicious for Escherichia coli O157: H7 infection (24%), systemic lupus erythematosus (18%), mitomycin C induced (12%), and preeclampsia (6%). A total of 229 TPE procedures were performed for 17 patients (mean: 13 procedures). The replacement fluids for TPE were fresh frozen plasma (59%) and cryosupernatant (41%). Thirteen patients (76%) survived and three of them relapsed (23%); however, they responded to further treatment. In comparing the laboratory results between pre and post TPE, significant changes were found in the white blood cells and platelet counts, creatinine, total bilirubin, and lactic dehydrogenase. The initial symptoms did not indicate a recurrence rate and a variety of drugs were used, except for corticosteroid administration. CONCLUSIONS: TTP/HUS patients responded well to TPE. The overall efficacy of TPE for TTP/HUS was 76%. The causes of TTP/HUS, the administered drugs and the replacement fluid did not affect the patient's prognosis.
Anemia, Hemolytic
;
Bilirubin
;
Creatinine
;
Escherichia coli O157
;
Female
;
Fever
;
Hemolytic-Uremic Syndrome
;
Humans
;
Leukocytes
;
Lupus Erythematosus, Systemic
;
Male
;
Mitomycin
;
Mortality
;
Neurologic Manifestations
;
Oxidoreductases
;
Pathology, Clinical
;
Plasma Exchange*
;
Plasma*
;
Platelet Count
;
Pre-Eclampsia
;
Prognosis
;
Recurrence
;
Retrospective Studies
;
Thrombocytopenia
6.The Effects of Cyclosporine on the Generation of ROS and Extracellular Matrix Accumulation in Cultured Human Mesangial Cells.
Hyun Ki CHAE ; Su Jeen LEE ; Hyun Jun KIM ; Gu KONG ; Kyoung Won KAHNG ; Chong Myung KANG
Korean Journal of Nephrology 2000;19(6):1024-1032
OBJECTIVE: Treatment with cyclosporine(CsA) for a long-term period may induce renal glomerulosclersosis and interstitial fibrosis. Reactive oxygen species(ROS) seems to be involved in the process of glomerulosclersosis and interstitial fibrosis. We investigated the effect of CsA on the generation of ROS and extracellular matrix accumulation in cultured human mesangial cells. We also studied the relationship between ROS formation and extracellular matrix and the effect of antioxidant on ROS formation and/or extracellular matrix degradation. METHODS: Mesangial cells were treated with varying dose of Cyclosporine(0, 2.5, 5, 7.5 and 10microgram/ mL) and also with cyclosporine(5microgram/mL) plus N- acetylcysteine(1mM). ROS was measured by flow cytometric analysis. mRNA expression of MMP-2, TIMP-2, MT1-MMP and collagen III was assessed by RT-PCR method. MMP-2 activity was measured by gelatin zymography. RESULTS: No significant difference was noted in cell viability with each CsA concentration. CsA inhibited the cell proliferation in a dose dependent manner and induced the expression of ROS. Antioxidant NAC reversed the effect of cyclosporine. CsA had no effect on the mRNA expression of collagen III, MMP-2, TIMP-2, MT1-MMP. However CsA decreased the MMP-2 activity in a dose dependent manner, which was also reversed by NAC. CONCLUSION: Cyclosporine-induced ROS may be associated with the extracellular matrix accumulation, that is glomerulosclersosis and interstitial fibrosis by inhibiting the cell proliferation and by decreasing the degradation of extracellular matrix. Antioxidant, at least in vitro, may prevent some of the adverse effects of CsA on renal function.
Cell Proliferation
;
Cell Survival
;
Collagen
;
Cyclosporine*
;
Extracellular Matrix*
;
Fibrosis
;
Gelatin
;
Humans*
;
Matrix Metalloproteinase 14
;
Mesangial Cells*
;
Oxygen
;
RNA, Messenger
;
Tissue Inhibitor of Metalloproteinase-2
7.Childhood Cancer Mortality and Birth Characteristics in Korea: A National Population-based Birth Cohort Study.
Eun Shil CHA ; Kyoung Ae KONG ; Eun Kyeong MOON ; Young Ho KHANG ; Won Jin LEE
Journal of Korean Medical Science 2011;26(3):339-345
To examine the relationship between birth characteristics and childhood cancer mortality, a retrospective cohort study of Korean children was conducted using data collected by the national birth register between 1995 and 2006, which were then individually linked to death data. A cohort of 6,479,406 children was followed from birth until their death or until December 31, 2006. Poisson regression analyses were used to calculate rate ratios of childhood cancer deaths according to birth characteristics. A total of 1,469 cancer deaths were noted and the childhood cancer mortality rate was found to be 3.43 per 100,000 person-years in Korea during the period of 1995-2006. The birth characteristics examined in this study (i.e. , birth weight, gestational age, multiple births, parental ages, and number of siblings) were generally found to be not significantly associated with childhood cancer mortality, and the associations did not vary meaningfully with gender nor with cancer sites. However, among children aged 5-11 yr, higher birth weight was associated with elevated childhood cancer mortality (rate ratio = 1.28, 95% confidence interval 1.04-1.58). Our results offer no overall associations between childhood cancer mortality and birth characteristics, but suggest that the association may be specific to age group.
Birth Weight
;
Child
;
Child, Preschool
;
Cohort Studies
;
Gestational Age
;
Humans
;
Multiple Birth Offspring
;
Neoplasms/*mortality
;
Parents
;
Republic of Korea
;
Retrospective Studies
;
Risk Factors
;
Siblings
;
Socioeconomic Factors
8.Increased expression of Galphaq protein in the heart of streptozotocin-induced diabetic rats.
Jung Mee YANG ; Chin Ho CHO ; Kyoung Ae KONG ; Ik Soon JANG ; Hae Won KIM ; Yong Sung JUHNN
Experimental & Molecular Medicine 1999;31(4):179-184
Heart disease is one of the major cause of death in diabetic patients, but the thogenesis of diabetic cardio-myopathy remains unclear. In this experiment, to sess the significance of G protein signaling pathways in the pathogenesis of abetic cardiomyopathy, we analyzed the expression of G proteins and the tivities of second messenger dependent protein kinases: cAMP-dependent protein nase (PKA), DAG-mediated protein kinase C (PKC), and calmodulin dependent otein kinase II (CaM kinase II) in the streptozotocin induced diabetic rat art. The expression of Galphaq was increased by slightly over 10% (P<0.05) in abetic rat heart, while Galphas, Galphai, and Gbeta remained unchanged. The A activity in the heart did not change significantly but increased by 27%<0.01) in the liver. Insulin treatment did not restore the increased activity the liver. Total PKC activity in the heart was increased by 56% (P<0.01), and sulin treatment did not restore such increase. The CaM kinase II activity in e heart remained at the same level but was slightly increased in the liver 4% increase, P<0.05). These findings of increased expression of Galphaq in the reptozotocin-diabetic rat heart that are reflected by the increased level of C activity and insensitivity to insulin demonstrate that alteration of Galphaq y underlie, at least partly, the cardiac dysfunction that is associated with abetes. Copyright 2000 Academic Press.
Animal
;
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism
;
Cyclic AMP-Dependent Protein Kinases/metabolism
;
Diabetes Mellitus, Experimental/metabolism*
;
Diabetes Mellitus, Experimental/drug therapy
;
Diabetes Mellitus, Experimental/chemically induced
;
GTP-Binding Proteins/metabolism*
;
Insulin/pharmacology
;
Liver/metabolism
;
Liver/drug effects
;
Male
;
Myocardium/metabolism*
;
Protein Kinase C/metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Signal Transduction
;
Streptozocin
9.A Case of an Adult-Onset Langerhans Cell Histiocytosis Involving the Temporal Bone.
Kwang Joong KIM ; Dae Keun LYM ; Won Kyoung KONG ; Seung Ho SHIN
Korean Journal of Otolaryngology - Head and Neck Surgery 2013;56(7):465-468
Langerhans cell histiocytosis (LCH) is a rare disease characterized by clonal proliferation of Langerhans cells. The temporal bone is frequently involved in pediatric LCH cases, but there have been few reports of adult LCH with temporal bone involvement. We present a case of adult onset LCH affecting the temporal bone. The diagnosis was made by biopsy, based on histopathologic findings of Langerhans cells. Diagnostic and therapeutic considerations of LCH involving the temporal bone are discussed.
Adult
;
Biopsy
;
Ear Canal
;
Histiocytosis, Langerhans-Cell
;
Humans
;
Langerhans Cells
;
Rare Diseases
;
Temporal Bone
10.National Cancer Incidence for the Year 2002 in Korea.
Hai Rim SHIN ; Kyu Won JUNG ; Young Joo WON ; Hyun Joo KONG ; Seon Hee YIM ; Joohon SUNG ; Sun Won SEO ; Ki Young KIM ; Sang Yi LEE ; In Sik KONG ; In Kyoung HWANG ; Choong Won LEE ; Ze Hong WOO ; Tae Yong LEE ; Jin Su CHOI ; Cheol In YOO ; Jong Myon BAE ; Keun Young YOO
Cancer Research and Treatment 2007;39(4):139-149
PURPOSE: Since the revised Cancer Act of October 2006, cancer registration was reactivated, based on the Statistics Law. MATERIALS AND METHODS: The incidence of cancer during 2002 was calculated on the basis of the information available from the National Cancer Incidence Database. Crude and age-standardized rates were calculated by gender for 18 age groups (0~4, 5~9, 10~14, every five years, 85 years and over). RESULTS: The overall crude incidence rates (CRs) were 269.2 and 212.8 per 100,000 for males and females, and the overall age-standardized incidence rates (ASRs) were 287.8 and 172.9 per 100,000, respectively. Among males, the five leading primary cancer sites were stomach (CR 62.4, ASR 65.7), lung (CR 45.4, ASR 51.0), liver (CR 43.2, ASR 43.7), colon and rectum (CR 30.7, ASR 32.7), and prostate (CR 8.0, ASR 9.6). Among females, the most common cancer sites were breast (CR 33.1, ASR 26.9), followed by stomach (CR 32.8, ASR 26.0), colon and rectum (CR 23.1, ASR 18.5), thyroid (CR 19.1, ASR 15.7), and uterine cervix (CR 18.2, ASR 14.7). In the 0~14 age group, leukemia was the most common cancer for both genders. For males, stomach cancer was the most common cancer in the 15~64 age-group, but lung cancer was more frequent in men 65 or older. For females, thyroid cancer among the 15~34 age-group, breast cancer among 35~64 age-group and stomach cancer in women 65 years or older were the most common forms of cancer for each age group. The quality indices for the percentage of deaths, by death certificate only, were 4.7% for males and 4.5% for females. CONCLUSIONS: Since the National Cancer Incidence Database was started, the annual percent change of cancer cases increased by 4.8% (4.1% for males, 5.7% for females) during 1999~2002. This value reflects the increase in prostate cancer for males and breast and thyroid cancer in females during 2002. The timely reporting of improved quality of cancer registration is needed for evidence-based decisions regarding cancer control in Korea.
Breast
;
Breast Neoplasms
;
Cervix Uteri
;
Colon
;
Death Certificates
;
Female
;
Humans
;
Incidence*
;
Jurisprudence
;
Korea*
;
Leukemia
;
Liver
;
Lung
;
Lung Neoplasms
;
Male
;
Prostate
;
Prostatic Neoplasms
;
Rectum
;
Stomach
;
Stomach Neoplasms
;
Thyroid Gland
;
Thyroid Neoplasms